Table 2 Patient demographics, BMI, HbA1c, insulin usage, and muscle/bone ratios among the study cohorts
Patient Data | Obese with T2DM (n = 31) | Non-obese with T2DM (n = 31) | Obese without T2DM (n = 31) | Non-obese without T2DM (n = 31) | P-value | |
|---|---|---|---|---|---|---|
Age, years (mean ± SD) | 60.7 ± 17.6 | 65.6 ± 18.0 | 36.4 ± 17.7 | 39.6 ± 17.4 |  < 0.001 | |
Gender | Female | 18 (58.1%) | 21 (67.7%) | 14 (45.2%) | 12 (38.7%) | 0.01 |
Male | 13 (41.9%) | 10 (32.3%) | 17 (54.8%) | 19 (61.3%) | Â | |
Race | Black | 15 (48.4%) | 20 (64.5%) | 15 (48.4%) | 10 (32.3%) | 0.09 |
White | 16 (51.6%) | 11 (35.5%) | 16 (51.6%) | 21 (67.7%) | Â | |
BMI, kg/m2 (mean ± SD) | 38.7 ± 2.7 | 25.6 ± 7.6 | 33.9 ± 8.8 | 24.4 ± 3.0 |  < 0.001 | |
HbA1c (mean ± SD) | 7.7% ± 1.6 (61 mmol/mol) | 7.2% ± 1.5 (55 mmol/mol) | ―――― | ―――― | 0.23 | |
Insulin usage | 17 (54.8%) | 11 (35.5%) | ―――― | ―――― | 0.13 | |
Muscle/Bone ratio |  |  |  |  |  |  < 0.001 |
| Â | Average | 0.54 | 0.48 | 0.42 | 0.35 | Â |
| Â | Median | 0.54 | 0.48 | 0.41 | 0.34 | Â |